Supply and Delivery of Anti-Tuberculosis Medicines to the Department of Health for the period 01 October 2027 to 30 September 2029Closed

Overview

Procurement of supplies and delivery of anti-tuberculosis medicines to the Department of Health for 01 Oct 2027 to 30 Sep 2029. Open-tender for pharmaceutical suppliers/distributors with SAHPRA medicine registrations, GMP and relevant licenses, capable of supplying 32 listed TB medicines across the contract period. Bid validity is 180 days.

Key bidders include pharmaceutical manufacturers and distributors with SAHPRA Medicine Registration Certificates (MRC) for offered items, GMP compliance, and the necessary licences to manufacture/import/distribute/wholesale medicines. The contract requires compliance with national procurement rules, NIP, and B-BBEE considerations.

Documents indicate mandatory bid forms (SBD/PBD), tax and supplier verifications (SARS PIN, CSD), and product registrations for all items (MRC) (see attached annexures).

Requirements

• Valid SAHPRA Medicine Registration Certificates (MRC) for each item offered; include MRC annexures.
• Good Manufacturing Practice and compliance with Medicines and Related Substances Act; GMP declaration.
• Licences to manufacture/import/distribute/wholesale medicines; include licence numbers and expiry.
• Tax and supplier compliance: SARS PIN/TCS, CSD registration; VAT registration; not in service of the state; director disclosures for single/multi-entity bids.
• B-BBEE: SANAS-accredited certificate or sworn affidavits for EME/QSE; points under 90/10 system.
• Bid documentation on official forms (SBD1, SBD4, PBD3, PBD4.1, PBD9.1/9.2 as applicable, PBD5 GMP, SBD5 NIP, etc.).
• Product sourcing disclosures if third parties are involved (PBD1 and undertakings from third parties).

Documents referenced for these requirements: Annexure A (mandatory documents), Annexure B (invoice data), and PBD/SBD forms in the bid pack.

How to Apply

• Obtain bid documents from the Department of Health website and the e-tender portal (HP01-2027TB bid pack and Excel bid response). See bid pack items and required forms in the attached files. (see 2.HP01-2027TB_Final-Bidpack31-July-2026.pdf)
• Briefing: non-compulsory online briefing on 14 August 2026 at 10:00 via MS Teams. (see 2.HP01-2027TB_Final-Bidpack31-July-2026.pdf)
• Submission deadline: 28 September 2026 at 11:00. Bids must be deposited in the Pharmaceutical Tender Box at the National Department of Health, DR AB Xuma Building, 1112 Voortrekker Road, Pretoria (or submitted electronically if the portal allows). (SBD1, 2.HP01-2027TB_Final-Bidpack31-July-2026.pdf)
• Submission method: electronic submission accepted; physical package required with Set 1 (printed bid), Set 2 (USB with scanned copies), Set 3 (Excel spreadsheets) as specified. Ensure outer packaging includes bid number, closing date, bidder name and contact. (2.HP01-2027TB_Final-Bidpack31-July-2026.pdf)
• Documents to submit: complete official forms (SBD1, SBD4, PBD3, PBD3.1, PBD4.1, PBD9.1/9.2 if applicable, PBD5 GMP, SBD5 NIP) and annexures; evidence of MRCs, CSD, tax clearance, LICs, and BBBEE status. (Annexure A; PBD5; SBD6.1)
• Queries: tenders@health.gov.za, with timely submission to receive responses before closing. (bid pack)

Notes:

• The final bid response items are listed in the Excel bid response (32 items with TB medicines listed; prices per unit/pack and delivery terms). (9. HP01-2027TB_Final BidResp_31 July 2026_Updated.xlsx)
• Invoice data requirements are specified in Annexure B (minimum data for invoices, including supplier details and PO alignment). (4. HP01-2027TB_Annexure B_Invoice requirements)